Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Minerva Endocrinologica 2017 September;42(3) > Minerva Endocrinologica 2017 September;42(3):280-9



Publication history
Per citare questo articolo


Rivista sulle Malattie del Sistema Endocrino

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383




Minerva Endocrinologica 2017 September;42(3):280-9

DOI: 10.23736/S0391-1977.16.02232-X


lingua: Inglese

Emergence of SFRP5 as a pleiotropic adipocytokine and its association with Wnt signaling pathways

Chandrasekaran JAIKANTH 1, Prema GURUMURTHY 1 , Thillai INDHUMATHI 2, Kotturathu M., CHERIAN 3

1 Department of Biochemical Pharmacology, Frontier Lifeline Hospital, Chennai, India; 2 Medical Officer, Take Care Hospital, Chennai, India; 3 Department of Cardiology, Frontier Lifeline Hospital, Chennai, India


The widespread perception of obesity as a non-communicable disease is slowly giving way to the view of a contagious, communicable and potentially fatal condition. The downstream comorbidities associated with it are endless. Hence, the slogan “Fat To Fit” is being promoted worldwide. The view of white adipose tissue as a fat storage organ is now shifting to an endocrine organ. The secreted hormones, called adipocytokines, act in an autocrine, paracrine, and endocrine fashion. Like other hormones, they can have a positive as well as a negative influence over the body. Secreted frizzled-related protein 5 (SFRP5) is a recently identified novel adipocytokine which falls under the category of those adipokines which have a positive influence on the system. Plasma SFRP5 levels are significantly lower in patients with obesity, insulin resistance and diabetes, a condition which contributes to the major components of the metabolic syndrome and to other disease conditions like atherosclerosis, autoimmune disorders, etc. This review article focuses on the effects of SFRP5 on the major systems of the body and on its association with the Wnt signaling pathways.

KEY WORDS: SFRP5 protein, human - Adipocytokines - Fat mass and obesity-associated protein, human - Metabolic diseases - Wnt signaling pathway

inizio pagina

Publication History

Issue published online: June 12, 2017
Article first published online: July 8, 2014
Manuscript accepted: June 29, 2014
Manuscript received: June 11, 2014

Per citare questo articolo

Jaikanth C, Gurumurthy P, Indhumathi T, Cherian KM. Emergence of SFRP5 as a pleiotropic adipocytokine and its association with Wnt signaling pathways. Minerva Endocrinol 2017;42:280-9. DOI : 10.23736/S0391-1977.16.02232-X

Corresponding author e-mail